About 511 Therapeutics
511 Therapeutics is a private company based in Cambridge, Massachusetts, incorporated in 2022 in Delaware. It has reported $549,999 raised in two offerings on Form D since October 2022. Its chief executive is Andrew Marshall.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 21, 2026 | Oct 30, 2026 | $500,000of $1.0M target | 1 | $500K | OptionsRule 506(b) | Form D ↗ |
| Sep 23, 2022 | Oct 6, 2022 | $49,999of $599K target | 1 | $49,999 | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $549,999 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on 511 Therapeutics's Form D filed Oct 30, 2026.